Open house Arzneimittelrabattverträge Infliximab, ATC L04AB02
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Infliximab, ATC L04AB02
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
Open-house agreement may be overridden by a later exclusive discount contract via formal procurement, causing automatic...
Strict submission requirements: paper documents in duplicate or qualified electronic signature. Incomplete or late subm...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Oct 2026
- Supply of Infliximab (ATC L04AB02) under non-exclusive discount agreements
- Open-house model; no selection or award procedure
Show full summary
Open-house model for non-exclusive discount agreements on Infliximab (ATC L04AB02) by AOK Bayern. All qualified pharmaceutical enterprises can join at any time until 05.09.2026. Contracts run from 01.11.2024 to 31.10.2026. No award criteria; eligibility requires only a signed declaration of reliability. No estimated value provided.
Risks
Open-house agreement may be overridden by a later exclusive discount contract via formal procurement, causing automatic...
Strict submission requirements: paper documents in duplicate or qualified electronic signature. Incomplete or late subm...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical enterprise
Administrative
- Submit signed declaration of reliability
- Submit signed contract and annex specifying the pharmaceutical product(s)
Requirements may be incomplete.
Buyer
Name
AOK Bayern - Die Gesundheitskasse
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Infliximab, ATC L04AB02
Non-exclusive discount agreements for Infliximab. Open to all pharmaceutical enterprises meeting eligibility. Contracts can be concluded anytime until 05.09.2026, starting on the 1st of the following month if complete documents are received by the 5th of a month.
Location
Duration
Category
Deadline
Award details
Selection criteria
Show original TED data
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Sep 2024
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 558403-2024
Documents (2)
Similar tenders
Germany – Heating, ventilation and air-conditioning installation work – VE BT11-4310-01 Lüftung
Belgium – Electrical supplies and accessories – Raamovereenkomst voor het leveren van verlichtingsarmaturen
Czechia – Vertical-spindle machining centre – Pořízení 5-osého CNC centra
Poland – Miscellaneous medical devices and products – Zakup i dostawa sprzętu i wyposażenia dla Zakładu Opiekuńczo-Leczniczego
Sweden – Water plumbing work – Ramavtal för entreprenader för schaktfri ledningsrenovering med flexibla foder
Poland – Miscellaneous evaluation or testing instruments – Zakup i dostawa do laboratoriów GIOŚ wyposażenia do zatężania ekstraktów chromatograficznych
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
Open-house agreement may be overridden by a later exclusive discount contract via formal procurement, causing automatic...
Strict submission requirements: paper documents in duplicate or qualified electronic signature. Incomplete or late subm...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications